Callisto Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
 |
|---|
| companiesandmarkets.com |
2009-11-16 04:17:21 -
Callisto Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/callisto-pha ..
Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal (GI) disorders and diseases. The Company operates through its two subsidiaries, Synergy Pharmaceuticals Inc. and Callisto Research Labs, LLC. The Companys lead drug candidates include SP-304, Atiprimod and L-Annamycin.
Callisto Pharmaceuticals, Inc. - Pharmaceuticals
& Healthcare - Deals and Alliances Profile
Summary
Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company. The company is focused on the development of novel therapeutics for the treatment of neuroendocrine cancer, acute leukemia and gastrointestinal disorders and diseases. The companys pipeline products include: Atiprimod, L-Annamycin and SP-304. It is headquartered at New York, United States.
The Callisto Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
